103 related articles for article (PubMed ID: 9571699)
1. Immunological enhancement of breast cancer.
Stewart TH; Heppner GH
Parasitology; 1997; 115 Suppl():S141-53. PubMed ID: 9571699
[TBL] [Abstract][Full Text] [Related]
2. Evidence for immune facilitation of breast cancer growth and for the immune promotion of oncogenesis in breast cancer.
Stewart TH
Medicina (B Aires); 1996; 56 Suppl 1():13-24. PubMed ID: 9224971
[TBL] [Abstract][Full Text] [Related]
3. Biological markers and breast cancer. A multiparametric study. II. Depressed immune competence.
Mandeville R; Lamoureux G; Legault-Poisson S; Poisson R
Cancer; 1982 Oct; 50(7):1280-8. PubMed ID: 6980699
[TBL] [Abstract][Full Text] [Related]
4. Towards an idiotype vaccine against mammary tumors. Induction of an immune response to breast cancer-associated antigens by anti-idiotypic antibodies.
Smorodinsky NI; Ghendler Y; Bakimer R; Chaitchuk S; Keydar I; Shoenfeld Y
Eur J Immunol; 1988 Nov; 18(11):1713-8. PubMed ID: 2849550
[TBL] [Abstract][Full Text] [Related]
5. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J
J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
[TBL] [Abstract][Full Text] [Related]
6. An experimental and clinical study of immunocompetence and immunostimulation in breast cancer.
Reynier J; Bazin JC; Bizzini B; Villet R; Chany C; Leandri S
Int Surg; 1988; 73(1):10-5. PubMed ID: 3360570
[TBL] [Abstract][Full Text] [Related]
7. Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response.
McKallip RJ; Nagarkatti M; Nagarkatti PS
J Immunol; 2005 Mar; 174(6):3281-9. PubMed ID: 15749859
[TBL] [Abstract][Full Text] [Related]
8. Cellular immunity in cancer: comparison of delayed hypersensitivity skin tests in three common cancers.
Bolton PM; Mander AM; Davidson JM; James SL; Newcombe RG; Hughes LE
Br Med J; 1975 Jul; 3(5974):18-20. PubMed ID: 1131654
[TBL] [Abstract][Full Text] [Related]
9. Molecular iodine exerts antineoplastic effects by diminishing proliferation and invasive potential and activating the immune response in mammary cancer xenografts.
Mendieta I; Nuñez-Anita RE; Nava-Villalba M; Zambrano-Estrada X; Delgado-González E; Anguiano B; Aceves C
BMC Cancer; 2019 Mar; 19(1):261. PubMed ID: 30902074
[TBL] [Abstract][Full Text] [Related]
10. Generation of a murine monoclonal antibody to normal mammary epithelium using mice rendered immune-tolerant to malignant mammary epithelium.
Imam SA; Esteban EF; Young LL; Taylor CR
J Histochem Cytochem; 1994 May; 42(5):585-91. PubMed ID: 7512585
[TBL] [Abstract][Full Text] [Related]
11. Immunity profile in breast cancer patients.
Hrubisko M; Sanislo L; Zuzulova M; Michalickova J; Zeleznikova T; Sedlak J; Bella V
Bratisl Lek Listy; 2010; 111(1):20-6. PubMed ID: 20429307
[TBL] [Abstract][Full Text] [Related]
12. Immunocompetence, immunosuppression, and human breast cancer. II. Further evidence of initial immune impairment by integrated assessment effect of nodal involvement (N) and of primary tumor size (T).
Adler A; Stein JA; Ben-Efraim S
Cancer; 1980 Apr; 45(8):2061-73. PubMed ID: 7370952
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
14. Immunocompetence, immunosuppression, and human breast cancer. III. Prognostic significance of initial level of immunocompetence in early and advanced disease.
Adler A; Stein JA; Ben-Efraim S
Cancer; 1980 Apr; 45(8):2074-83. PubMed ID: 7370953
[TBL] [Abstract][Full Text] [Related]
15. Immunological relatedness of a murine mammary tumor-associated antigen and human breast cancer.
Chattopadhyay J; Chattopadhyay U; Chowdhury JR
Gan; 1984 Apr; 75(4):342-8. PubMed ID: 6329885
[TBL] [Abstract][Full Text] [Related]
16. Antitumor immunity in breast cancer patients. Biologic and therapeutic implications.
Black MM; Zachrau RE
J Reprod Med; 1979 Jul; 23(1):21-32. PubMed ID: 226697
[TBL] [Abstract][Full Text] [Related]
17. Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases.
Aprelikova O; Tomlinson CC; Hoenerhoff M; Hixon JA; Durum SK; Qiu TH; He S; Burkett S; Liu ZY; Swanson SM; Green JE
PLoS One; 2016; 11(5):e0155262. PubMed ID: 27171183
[TBL] [Abstract][Full Text] [Related]
18. [Immunological cross reaction between human breast cancer and mammopathy and virus-producing breast carcinomas of the mouse].
Müller M; Zotter S; Grossmann H; Kemmer C
Arch Geschwulstforsch; 1972; 40(4):285-99. PubMed ID: 4346686
[No Abstract] [Full Text] [Related]
19. Implications of humoral antibody in mice and humans to breast tumor and mouse mammary tumor virus-associated antigens.
Bowen JM; Dmochowski L; Miller MF; Priori ES; Seman G; Dodson ML; Maruyama K
Cancer Res; 1976 Feb; 36(2 pt 2):759-64. PubMed ID: 175935
[TBL] [Abstract][Full Text] [Related]
20. Mammary gland neoplasia in long-term rodent studies.
Russo IH; Russo J
Environ Health Perspect; 1996 Sep; 104(9):938-67. PubMed ID: 8899375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
